FDA Approved: ALVESCO — Supplemental Application (Covis Pharma US, Inc)

View source ↗

Summary

The FDA approved Covis Pharma US's supplemental application for Alvesco (ciclesonide), resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Alvesco (ciclesonide)

Snippet

SUPPL AP for ALVESCO (CICLESONIDE)